Viral Hepatitis Coinfection

Resources: 49

Passport to Cure

Passport to Cure is an interactive patient engagement brochure. It helps clients track clinic visits and monitor their HCV treatment progress to achieve a sustained viral response. It folds down to a...

Publication Date

In Brief: HIV and Hepatitis News

The final issue of In Brief was published on December 20, 2022. The In Brief Newsletter Archives provides information on HIV and viral hepatitis including prevention, treatment, the continuum of care,...

Publication Date

Hep C Free Postcard

The Hep C Free postcard is designed to celebrate and acknowledge patient success when hepatitis C viral suppression is achieved. It also serves as a reminder of the risk factors that can lead to HCV r...

Publication Date

Hepatitis C Online

Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for Disease Control and Prevention (CDC).


Publication Date

Hepatitis C Treatment Update

Training slides provide an epidemiology update, review new AASLD/IDSA practice guidelines, review what to do with treatment interruptions and discuss pregnancy and HCV therapy.

Documents with preview...

Publication Date

HIV Resource Library

New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health topics.

Each Library topic page is an organized li...

Publication Date

Hepatitis C Toolkit Curriculum

The purpose of this training is to improve providers’ capacity to screen, medically manage, and provide advanced care for patients with hepatitis C virus (HCV).

Learning Objectives

  • Identify risk factors...
Publication Date

HIV/HCV Molecular Cluster Detection

Training slides provide an overview of molecular cluster detection, the steps needed to incorporate molecular cluster detection into a comprehensive HIV/HCV cluster detection outbreak response plan, a...

Publication Date

Management of HCV and HIV Coinfection

Training slides provide updates on HCV-HIV coinfection management including epidemiology, pre-treatment assessment, treatment options, recommendations, and outcomes for people coinfected with HCV and...

Publication Date

Hepatitis C: Drug-Drug Interactions

Training slides learning objections include:

  • Understanding the mechanism of action for drug interactions with hepatitis C medications
  • Recognizing which medications should be avoided in co-administration...
Publication Date

National HIV Curriculum & Promotional Resources

The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 lessons and corresponding question bank topics offer...

Publication Date

Corrections Video Series

Created in collaboration with Southeast AETC's South Carolina partner, this animated video series provides guides to basic HIV and HCV discussions. Its target audience is healthcare professionals who...

Publication Date

Hepatitis C Update


This Training Presentation demonstrates how to understand the updated screening recommendations. Learn about treatment regimens for patients in primary care settings. Identify patients tha...

Publication Date

Benefits of SVR Post-DAA Therapy


These training slides summarize the progress of HIV Antiretroviral Medication and New Mechanisms of Action. Information on New Medications Dosing and Administration and exemplary Case Stud...

Publication Date

Resources: 5

HCV Pretreatment Evaluation


  • Describe how to evaluate likelihood of disease progression
  • Discuss importance of and methods for staging liver disease
  • Explain how to assess patient readiness for treatment
  • Summarize key aspect...
Publication Date

Articles: 3

NCCC Clinical Pearls: HCV Treatment Interruption

Case Summary

A 67-year-old cisgender male with chronic HCV mono-infection was seen for treatment evaluation.  He had no history of prior HCV treatment, and initial assessment revealed genotype 1a and a fibrosis score of F3/F4.  Direct-acting antiviral (DAA) therapy using 12-weeks of sofosbuvir/velpat...